Post Categories
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials…
Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
October 14, 2024
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability…
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge…
New Cancer Treatment Modality Goes into Phase I
September 18, 2024
Prostate cancer is the second most common cancer in men worldwide, making the search for effective treatments an urgent imperative for the medical community….
Breaking Ground in Cancer Treatment: First T-Cell Therapy Approved for Solid Tumors
September 16, 2024
Tecelra®, the first engineered T-cell therapy for solid tumors, has received approval from the Food and Drug Administration (FDA) for advanced MAGE-A4+ synovial sarcoma…
Medicare Price Cuts Promise Relief to Seniors
September 9, 2024
In a historic move, the White House announced steep price reductions for ten prescription drugs under Medicare thanks to the Inflation Reduction Act (IRA)….
Can Repeat Dosing with RNA Medicines Be Curative?
August 26, 2024
Exsilio Therapeutics, a Boston-based biotech startup, has secured $82 million in funding and hopes to target genetic conditions with a new approach to gene…
FDA Approves New Drug for Food Allergies
August 21, 2024
For individuals with life-threatening food allergies, everyday activities like dining out and traveling can be tremendously stressful, as even the smallest traces of the…
Game-Changing Drug for Colon Cancer May Redefine Treatment
August 19, 2024
Clinical trial results show that pembrolizumab, an immunotherapy drug used to treat multiple types of cancer, can dramatically improve outcomes for patients with colorectal…
Cracking Cancer’s Spread: New Target Identified to Block Bone Metastasis
July 21, 2025
Cancer’s cruelest trick might be its ability to migrate from its initial site and invade other organs and systems, with bones being one of…
What Happens When Your Mind Goes Blank?
July 16, 2025
You walk into a room with a purpose, but then forget what you planned to do there. You open your phone to text a…
Oncology: How Losing the Y Chromosome Affects Outcomes
July 14, 2025
Hair thinning and loss are highly visible and common changes associated with aging in men. At the same time, many men experience cellular changes…
Solving the Protein Puzzle: How Much Protein Do You Really Need?
July 7, 2025
From protein shakes to high-protein plans like the Paleo and Atkins diets, protein is all the rage for building muscle and losing weight. However,…
Got a Case of “Marathon Brain?” Research Explains Why
June 25, 2025
Running 26.2 miles may not be everyone’s idea of a good time — but marathon running is booming, with participation surging at races around…
Less Sitting, More Living: How Activity Reduces Risk for Heart Attack Survivors
June 24, 2025
Sitting down might seem harmless, but for heart attack survivors, prolonged sedentary time could spell significant trouble. According to recent research, replacing just 30…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…